Search
for
Sort by
Research 961–990 of 1000+
- Oral Contraceptives and Cyproterone Acetate in Female Acne Treatment
- Polymeric micelle mediated follicular delivery of spironolactone: Targeting the mineralocorticoid receptor to prevent glucocorticoid-induced activation and delayed cutaneous wound healing
- Hair loss
- Medical treatment of male pattern alopecia (androgenic alopecia)
- ADT-G as a promising biomarker for peripheral hyperandrogenism in adult female acne
- Engineered Exosomes Co-Delivering EGF and FGF Ameliorate Androgenetic Alopecia in a Mouse Model
- Medical Treatment for Androgenetic Alopecia
- A SIBO-mediated aetiology for a subset of Post-Finasteride Syndrome cases: investigating gut-derived toxins
- A SIBO-mediated aetiology for a subset of Post-Finasteride Syndrome cases: investigating gut-derived toxins
- Recent approaches of antibody therapeutics in androgenetic alopecia
- Insights into disparities observed with COVID‐19
- Inhibition of 17α-hydroxylase/C17,20 lyase reduces gating deficits consequent to dopaminergic activation
- Updates on Therapeutic Approaches for Management of Androgenetic Alopecia: A Review
- Engineered Exosomes Co-Delivering EGF and FGF Ameliorate Androgenetic Alopecia in a Mouse Model
- Age-dependent endocrine disorders involved in the pathogenesis of refractory acne in women
- Permanent Alopecia After Systemic Chemotherapy: A Clinicopathological Study of 10 Cases
- Anti-androgen therapy in dermatology: a review
- Systemic causes of hair loss
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- Salivary Inflammatory Markers and Free Androgen Index in Women with Polycystic Ovary Syndrome: A Case-Control Study
- Hidradenitis suppurativa: an-androgen-dependent disorder
- Activation of nuclear factor κB in response to cream ingestion is related to ovarian androgen hypersecretion in polycystic ovary syndrome
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
- Regulatory roles of androgens in cutaneous wound healing
- Androgens in women
- Topical use of systemic drugs in dermatology: A comprehensive review
- Polymorphism of CAG and GGN repeats of androgen receptor gene in women with polycystic ovary syndrome
- The role of androgen therapy
- Pantolactams as androgen receptor antagonists for the topical suppression of sebum production
- Evaluation of COVID-19 risk in patients on systemic retinoid therapy